Category:
Other Antibiotics
CAS NO:
183133-96-2
Standard:
In-house Standards,
R&D
Cabazitaxel is a third-generation taxane chemotherapy agent synthesized via semi-synthesis from natural precursors. Its molecular formula is C46H57NO14, and it carries the CAS registry number 209287-28-5. The core manufacturing process involves precise chemical modification to enhance solubility and efficacy against resistant tumor lines.
Strictly contraindicated for patients with severe neutropenia or hypersensitivity to polysorbate 80. Requires storage at controlled room temperature (20°C–25°C) in light-resistant containers. Personnel must utilize appropriate PPE during handling due to cytotoxicity risks.